Related Experiment Video
Updated: Jul 6, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Gut, inflammation and osteoporosis: basic and clinical concepts
1Christian Doppler Research Laboratory for Gut Inflammation and Division of Gastroenterology and Hepatology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. herbert.tilg@i-med.ac.at
Chronic inflammatory diseases like IBD are linked to osteoporosis. Targeting tumour necrosis factor-alpha (TNF-alpha) may treat inflammation-related bone loss.
Area of Science:
- Immunology and Bone Metabolism
- Gastroenterology and Rheumatology
Background:
- Chronic inflammatory disorders, including inflammatory bowel diseases (IBD), significantly impact bone metabolism, often leading to osteoporosis.
- Pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), IL-6, and interferon-gamma, are key regulators of bone loss in these conditions.
- TNF-alpha, a central cytokine in IBD, induces bone erosions via osteoclast activity, and related molecules like RANKL and osteoprotegerin are implicated in gut inflammation and bone pathophysiology.
Purpose of the Study:
- To explore the role of inflammation, particularly TNF-alpha, in the development of osteoporosis associated with chronic inflammatory diseases.
- To investigate the potential of targeting TNF-alpha as a therapeutic strategy for inflammation-related osteoporosis.
Main Methods:
- Review of existing literature on inflammatory mediators, bone metabolism, and osteoporosis in IBD and coeliac disease.
- Analysis of the role of TNF-alpha and related cytokines in both gut inflammation and bone pathophysiology.
Main Results:
- Inflammation, driven by cytokines like TNF-alpha, is a significant contributor to bone loss in chronic inflammatory conditions.
- TNF-alpha directly affects osteoclasts, leading to bone erosions and contributing to osteoporosis.
- Existing therapies like bisphosphonates may help, but targeting the underlying inflammation is crucial.
Conclusions:
- Inflammation is a critical, often overlooked, factor in osteoporosis associated with IBD and coeliac disease.
- Neutralisation of TNF-alpha presents a promising future therapeutic strategy for treating inflammation-related osteoporosis.
- Early diagnosis and management of osteoporosis in chronic inflammatory states are essential.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
Bone Remodeling
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...